Regulation of cerebrospinal fluid production by caffeine consumption

BMC Neuroscience

Volumn 10, Issue , 2009, Pages 110-

  Han, Myoung Eun ^a,b   Kim, Hak Jin ^a   Lee, Young Suk ^a   Kim, Dong Hyun ^a   Choi, Joo Taek ^a   Pan, Chul Sik ^a   Yoon, Sik ^a,b   Baek, Sun Yong ^a   Kim, Bong Seon ^a   Kim, Jae Bong ^a   Oh, Sae Ock ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CAFFEINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEVERAGE; BRAIN BLOOD FLOW; BRAIN TISSUE; BRAIN VENTRICLE DILATATION; CEREBROSPINAL FLUID; CHOROID PLEXUS; CONTROLLED STUDY; DIETARY INTAKE; ENZYME REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NEUROMODULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; BRAIN CIRCULATION; BRAIN VENTRICLE; DRUG EFFECT; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAFFEINE; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID; CEREBROVASCULAR CIRCULATION; CHOROID PLEXUS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; SODIUM-POTASSIUM-EXCHANGING ATPASE; THEOPHYLLINE;

EID: 70349578544     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-10-110     Document Type: Article

References (45)

1. Howell LL, Coffin VL, Spealman RD. Behavioral and physiological effects of xanthines in nonhuman primates. Psychopharmacology 1997, 129(1):1-14.
2. Angelucci ME, Cesario C, Hiroi RH, Rosalen PL, Da Cunha C. Effects of caffeine on learning and memory in rats tested in the Morris water maze. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica 2002, 35(10):1201-1208.
3. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacological reviews 1994, 46(2):143-156.
4. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological reviews 1999, 51(1):83-133.
5. Field AS, Laurienti PJ, Yen YF, Burdette JH, Moody DM. Dietary caffeine consumption and withdrawal: confounding variables in quantitative cerebral perfusion studies?. Radiology 2003, 227(1):129-135.
6. Nehlig A. Are we dependent upon coffee and caffeine? A review on human and animal data. Neuroscience and biobehavioral reviews 1999, 23(4):563-576.
7. Zhao G, Messina E, Xu X, Ochoa M, Sun HL, Leung K, Shryock J, Belardinelli L, Hintze TH. Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist. Journal of cardiovascular pharmacology 2007, 49(6):369-375.
8. El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM. Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology 2003, 45(7):977-985.
9. Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB, Urade Y, Hayaishi O. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nature neuroscience 2005, 8(7):858-859.
10. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997, 388(6643):674-678.
11. Albertson TE, Joy RM, Stark LG. Caffeine modification of kindled amygdaloid seizures. Pharmacol Biochem Behav 1983, 19(2):339-343.
12. Ault B, Olney MA, Joyner JL, Boyer CE, Notrica MA, Soroko FE, Wang CM. Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy. Brain Res 1987, 426(1):93-102.
13. Georgiev V, Johansson B, Fredholm BB. Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res 1993, 612(1-2):271-277.
14. Johansson B, Georgiev V, Kuosmanen T, Fredholm BB. Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. Eur J Neurosci 1996, 8(12):2447-2458.
15. von Lubitz DK, Dambrosia JM, Kempski O, Redmond DJ. Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus. Stroke 1988, 19(9):1133-1139.
16. Rudolphi KA, Keil M, Fastbom J, Fredholm BB. Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci Lett 1989, 103(3):275-280.
17. Sutherland GR, Peeling J, Lesiuk HJ, Brownstone RM, Rydzy M, Saunders JK, Geiger JD. The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology. Neuroscience 1991, 42(1):171-182.
18. Bayne K. Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. The Physiologist 1996, 39(4):199. 208-111..
19. Mao X, Enno TL, Del Bigio MR. Aquaporin 4 changes in rat brain with severe hydrocephalus. The European journal of neuroscience 2006, 23(11):2929-2936.
20. Fredholm BB, Herrera-Marschitz M, Jonzon B, Lindstrom K, Ungerstedt U. On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat. Pharmacology, biochemistry, and behavior 1983, 19(3):535-541.
21. Kaplan GB, Greenblatt DJ, Leduc BW, Thompson ML, Shader RI. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity. The Journal of pharmacology and experimental therapeutics 1989, 248(3):1078-1083.
22. Chodobski A, Szmydynger-Chodobska J, Johanson CE. Vasopressin mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation. European journal of pharmacology 1998, 347(2-3):205-209.
23. Akaiwa K, Akashi H, Harada H, Sakashita H, Hiromatsu S, Kano T, Aoyagi S. Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation. Brain research 2006, 1122(1):47-55.
24. Xiao D, Bastia E, Xu YH, Benn CL, Cha JH, Peterson TS, Chen JF, Schwarzschild MA. Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice. J Neurosci 2006, 26(52):13548-13555.
25. Poleszak E, Malec D. Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats. Polish journal of pharmacology 2003, 55(3):319-326.
26. Riyamongkol P, Zhao W, Liu Y, Belayev L, Busto R, Ginsberg MD. Automated registration of laser Doppler perfusion images by an adaptive correlation approach: application to focal cerebral ischemia in the rat. Journal of neuroscience methods 2002, 122(1):79-90.
27. Han ME, Park KH, Baek SY, Kim BS, Kim JB, Kim HJ, Oh SO. Inhibitory effects of caffeine on hippocampal neurogenesis and function. Biochemical and biophysical research communications 2007, 356(4):976-980.
28. Barone JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol 1996, 34(1):119-129.
29. Meiniel A. The secretory ependymal cells of the subcommissural organ: which role in hydrocephalus?. The international journal of biochemistry & cell biology 2007, 39(3):463-468.
30. Praetorius J. Water and solute secretion by the choroid plexus. Pflugers Arch 2007, 454(1):1-18.
31. Faraci FM, Mayhan WG, Heistad DD. Effect of vasopressin on production of cerebrospinal fluid: possible role of vasopressin (V1)-receptors. The American journal of physiology 1990, 258(1 Pt 2):R94-98.
32. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatric research 2001, 50(5):553-562.
33. Turner CP, Seli M, Ment L, Stewart W, Yan H, Johansson B, Fredholm BB, Blackburn M, Rivkees SA. A1 adenosine receptors mediate hypoxia-induced ventriculomegaly. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(20):11718-11722.
34. Wendler CC, Amatya S, McClaskey C, Ghatpande S, Fredholm BB, Rivkees SA. A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(23):9697-9702.
35. Back SA, Craig A, Luo NL, Ren J, Akundi RS, Ribeiro I, Rivkees SA. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Annals of neurology 2006, 60(6):696-705.
36. Johansson B, Ahlberg S, Ploeg I, Brene S, Lindefors N, Persson H, Fredholm BB. Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn-Schmiedeberg's archives of pharmacology 1993, 347(4):407-414.
37. Shi D, Nikodijevic O, Jacobson KA, Daly JW. Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain. Cellular and molecular neurobiology 1993, 13(3):247-261.
38. Shi D, Daly JW. Chronic effects of xanthines on levels of central receptors in mice. Cellular and molecular neurobiology 1999, 19(6):719-732.
39. Shi D, Nikodijevic O, Jacobson KA, Daly JW. Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice. Archives internationales de pharmacodynamie et de therapie 1994, 328(3):261-287.
40. Conlay LA, Conant JA, deBros F, Wurtman R. Caffeine alters plasma adenosine levels. Nature 1997, 389(6647):136.
41. Yang JN, Bjorklund O, Lindstrom-Tornqvist K, Lindgren E, Eriksson TM, Kahlstrom J, Chen JF, Schwarzschild MA, Tobler I, Fredholm BB. Mice heterozygous for both A1 and A(2A) adenosine receptor genes show similarities to mice given long-term caffeine. J Appl Physiol 2009, 106(2):631-639.
42. Ngai AC, Winn HR. Effects of adenosine and its analogues on isolated intracerebral arterioles. Extraluminal and intraluminal application. Circulation research 1993, 73(3):448-457.
43. Ngai AC, Coyne EF, Meno JR, West GA, Winn HR. Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. American journal of physiology 2001, 280(5):H2329-2335.
44. Yang JN, Chen JF, Fredholm BB. Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. American journal of physiology 2009, 296(4):H1141-1149.
45. Lankford AR, Byford AM, Ashton KJ, French BA, Lee JK, Headrick JP, Matherne GP. Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors. Physiological genomics 2002, 11(2):81-89.